Results 71 to 80 of about 266,500 (305)

Hemodialysis

open access: yesThe Professional Medical Journal, 2012
Background: Chronic renal failure / End stage renal disease is not only a medical illness but it also has wide ranging effects onthe patient and his family. Objectives: The objective of the study was to evaluate socio-economic impact of hemodialysis on patientsundergoing dialysis Setting: DHQ Teaching Hospital, Sargodha.
Jeffrey N. Harr   +80 more
openaire   +3 more sources

POS-699 BORDERLINE REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS: WHERE DOES THE TREATMENT STAND

open access: yesKidney International Reports, 2021
M. MOJAAT   +8 more
doaj   +1 more source

Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease

open access: yesRenal Failure
Hemodialysis (HD) is a life-sustaining treatment for chronic kidney disease (CKD) patients. This study aimed to identify candidate diagnostic biomarkers associated with HD-treated CKD.
Guoxin Zhang, Jieqiong Fu, Wenming Niu
doaj   +1 more source

Home Hemodialysis [PDF]

open access: yesAdvances in Chronic Kidney Disease, 2021
openaire   +2 more sources

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

Analyzing Vertical Mergers to Avoid False Negatives: Three Recent Case Studies [PDF]

open access: yes, 2019
This article analyzes three recent vertical mergers: a private antitrust case attacking the consummated merger of Jeld-Wen and Craftmaster Manufacturing Inc. (“CMI”) that was cleared by the DOJ in 2012 but subsequently litigated and won by the plaintiff,
Salop, Steven C.
core   +1 more source

Mucocutaneous manifestations and nail changes in patients with end-stage renal disease on hemodialysis. [PDF]

open access: yes, 2013
Mucocutaneous manifestations are common among patients on hemodialysis (HD). This study was undertaken to determine the prevalence of mucocutaneous manifestations in patients with end-stage renal disease (ESRD) who are on HD.
Azarhoosh, R.   +7 more
core   +2 more sources

The Risk Factors of Hypotension in Patients with End-Stage Chronic Glomerulonephritis During Maintenance Hemodialysis

open access: yesInternational Journal of General Medicine
Qiaoxia Chen, Juanjuan Chen, Yanjuan Teng Department of Nursing, Shanghai Sixth People’s Hospital, Shanghai, 200233, People’s Republic of ChinaCorrespondence: Yanjuan Teng, Department of Nursing, Shanghai Sixth People’s Hospital, 600 Yishan Road ...
Chen Q, Chen J, Teng Y
doaj  

POS-317 PREVALENCE OF CHRONIC KIDNEY DISEASE IN THE SUBJECT OF THE YOUNG NEPHROLOGY DEPARTMENT OF THE NATIONAL HOSPITAL DONKA

open access: yesKidney International Reports, 2021
S.B. Mamadou   +7 more
doaj   +1 more source

Porphyria Cutanea Tarda in a Patient with End-Stage Renal Disease: A Case of Successful Treatment with Deferoxamine and Ferric Carboxymaltose

open access: yesCase Reports in Nephrology, 2017
Porphyria cutanea tarda (PCT) is a rare disease, with a strong association with hepatitis C virus. PCT is particularly problematic in end-stage renal disease patients as they have no renal excretion of porphyrins and these are poorly dialyzed.
Natacha Rodrigues   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy